Viewing Study NCT04774068


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2026-01-03 @ 8:21 AM
Study NCT ID: NCT04774068
Status: COMPLETED
Last Update Posted: 2025-01-17
First Post: 2021-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas
Sponsor: Walter Hanel
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module